Kyowa Kirin Australia
Kyowa Kirin strives to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Since 2000, Kyowa Kirin carved and established a niche in certain parts of Asia Pacific with a focus on providing effective patient care therapies in haematology.
For more than a decade, Kyowa Kirin has invested our efforts towards leveraging innovation and technological advancements to further enhance patient experience and the patient value across therapeutic areas that are less approached.
To bring these advances to Australians we established Kyowa Kirin Australia in 2019. As part of Kyowa Kirin Asia Pacific, our Australian operation is headquartered in the Sydney CBD.
Aspiring for a patient-care journey through our cutting-edge technology
In the core therapeutic areas of Oncology, Nephrology, Immunology & Allergy, and Central Nervous System, Kyowa Kirin has leading edge biotechnology centred on antibody know-how and pathways to innovative new drugs.
In this way, the company is working to realise a vision of becoming a Japan-based global specialty pharmaceutical company that contributes to the health and well-being of people around the world.
You can learn more about our global business at www.kyowakirin.com.
Kyowa Kirin Asia Pacific aspires to collaborate with our counterparts to contribute to the health and well-being of people around the world by creating new value through the pursuits of advances in science and technologies.